11 results about "Polygala tenuifolia" patented technology

This invention provides a traditional Chinese medicine composition, preparation method, and application for treating frequent urination with incontinence in various postmenopausal symptoms. The traditional Chinese medicine composition, by weight, consists of the following raw materials: Astragalus membranaceus 10-20 parts, Codonopsis pilosula 10-15 parts, Atractylodes macrocephala 7.5-10 parts, Ziziphus jujuba var. spinosa 10-15 parts, Mantis religiosa ootheca 4-5 parts, Paeonia lactiflora 7.5-15 parts, Rehmannia glutinosa 6-10 parts, Angelica sinensis 7.5-10 parts, Cinnamomum cassia 1.5-2.5 parts, Poria cocos 6-7.5 parts, Lindera strychnifolia 5-6 parts, Schisandra chinensis 5-6 parts, Psoralea corylifolia 4-6 parts, Alpinia oxyphylla 4-6 parts, Citrus reticulata 4-6 parts, Polygala tenuifolia 3-4 parts, Cane sucrose (peeled) 10-30 parts, Zingiber officinale (peeled) 5-7.5 parts, Ziziphus jujuba 5-7.5 parts, and Glycyrrhiza uralensis (processed) 3-4 parts. The traditional Chinese medicine composition of the present invention has definite curative effect, is safe to use, and has no obvious toxic side effects.

This invention discloses an auricular acupressure pellet for treating epileptic seizures, as well as its preparation and usage methods. The auricular acupressure pellet is composed of the following ingredients in the indicated weight percentages: Gastrodia elata 25-35 parts, Fritillaria cirrhosa 25-35 parts, Pinellia ternata 25-35 parts, Poria cocos 25-35 parts, Poria cocos sclerotium 25-35 parts, Bambusa textilis 10-20 parts, Acorus tatarinowii 10-20 parts, Buthus martensii 3-9 parts, Bombyx mori 3-9 parts, Amber 10-20 parts, Uncaria rhynchophylla 10-20 parts, Citrus reticulata 5-12 parts, Polygala tenuifolia 10-15 parts, Salvia miltiorrhiza 25-35 parts, Ophiopogon japonicus 25-35 parts, Margarita 25-35 parts, and Dragon bone 25-35 parts. This invention solves the problems of limited efficacy and inconvenience in use of existing technologies, providing a highly efficient and safe new option for the treatment of epileptic seizures.

This invention discloses a traditional Chinese medicine composition with calming and sleep-aiding effects and its preparation method, relating to the field of pharmaceutical technology. The traditional Chinese medicine composition with calming and sleep-aiding effects comprises the following raw materials in parts by weight: 15-25 parts of vetiver volatile oil, 15-25 parts of valerian volatile oil, 8-12 parts of sandalwood volatile oil, 8-12 parts of cyperus rotundus volatile oil, 8-12 parts of albizia julibrissin bark volatile oil, 5-8 parts of orange blossom volatile oil, 8-12 parts of polygala tenuifolia volatile oil, 8-12 parts of schisandra chinensis volatile oil, 5-8 parts of jasmine volatile oil, and 500-520 parts of fractionated coconut oil. This invention also provides a method for preparing the traditional Chinese medicine composition with calming and sleep-aiding effects, effectively solving the problems of existing sleep aid products that easily cause liver and kidney metabolic burden, gastrointestinal irritation, uncontrollable dosage of active ingredients, and ingestion of ineffective ingredients.

This invention relates to the field of traditional Chinese medicine preparations, specifically a chewable tablet for adjuvant treatment of myopia and its preparation method, comprising the following raw materials and excipients in parts by weight: Codonopsis pilosula 150-220 parts, Angelica sinensis 150-220 parts, Lycium barbarum 300-500 parts, Poria cocos 40-70 parts, Ophiopogon japonicus 50-80 parts, Alisma plantago-aquatica 35-50 parts, Schisandra chinensis 30-40 parts, Acorus tatarinowii 30-40 parts, Paeonia suffruticosa 35-50 parts, and Polygala tenuifolia (processed with licorice water) 30-40 parts; excipients: mannitol 120-160 parts, sucrose 220- 300 parts, 1-3 parts steviol glycosides, 3-5 parts magnesium stearate, 30-35 parts gastric-soluble film-coating premix, and an appropriate amount of 40-60% ethanol; This invention achieves the effects of tonifying qi and blood, nourishing the liver and kidneys through traditional Chinese medicines such as Codonopsis pilosula, Angelica sinensis, and Lycium barbarum, combined with the effects of Acorus tatarinowii and Polygala tenuifolia in opening the orifices and calming the mind. It has a significant effect on improving vision and relieving eye muscle spasms, especially for myopia, particularly pseudomyopia and eye fatigue in adolescents. The formulation of this invention strictly follows the traditional treatment principles of tonifying qi and blood, nourishing the liver and kidneys, and improving vision and calming the mind. The effective ingredient content is clear and the effect is stable.

A composition for improving skin comprising extracts of Polygala tenuifolia, Angelica dahurica and Elsholtzia splendens is described. The composition is excellent in effects of improving skin inflammation, antioxidant effects, antibacterial effects on skin, and skin moisturizing effects, and thus can be used as a cosmetic for improving skin, and further, as a pharmaceutical composition for treating inflammatory skin diseases.

This invention relates to the field of treatment technology for phlegm-stasis type cerebral small vessel disease, and particularly to a traditional Chinese medicine composition and its preparation method for treating cognitive impairment related to cerebral small vessel disease. The traditional Chinese medicine composition is made from the following traditional Chinese medicines in parts by weight: 10 parts of Trichosanthes kirilowii, 10 parts of Pinellia ternata, 15 parts of Citrus reticulata peel, 12 parts of Atractylodes macrocephala, 12 parts of Ligusticum chuanxiong, 30 parts of Salvia miltiorrhiza, 6 parts of Hirudo medicinalis, 15 parts of Crataegus pinnatifida (roasted), 12 parts of Polygala tenuifolia, 12 parts of Cistanche deserticola, 6 parts of Glycyrrhiza uralensis, 15 parts of Spatholobus suberectus, and 15 parts of Acorus tatarinowii. The traditional Chinese medicine composition and its preparation method provided by this invention target the core pathogenesis of cognitive impairment in cerebral small vessel disease, namely "phlegm and blood stasis obstructing the orifices." Through multiple pathways of action—resolving phlegm and removing blood stasis, clearing the channels and opening the orifices, and benefiting intelligence and calming the mind—it improves cerebral microcirculation, reduces neuroinflammation, and protects neurons, thereby improving cognitive function.

This invention belongs to the field of traditional Chinese medicine technology, specifically relating to a traditional Chinese medicine composition, preparation method, pharmaceutical formulation, and application for treating cerebellar ataxia syndrome. The composition comprises the following components: Rehmannia glutinosa (raw and processed), Cistanche deserticola, Morinda officinalis, Cornus officinalis, Dendrobium nobile, Curculigo orchioides, Panax ginseng, Ophiopogon japonicus, Polygala tenuifolia, Acorus tatarinowii, Angelica dahurica, Poria cocos, Schisandra chinensis, Citrus reticulata peel, and Amomum villosum. The preparation method involves first soaking Rehmannia glutinosa (raw and processed) to obtain mixture A; then mixing the remaining ingredients and soaking them in water to obtain mixture B; finally, combining mixture A and mixture B, and decocting to obtain the final product. This traditional Chinese medicine formula can treat cerebellar ataxia syndrome, improving the main symptoms of ataxia such as gait instability, balance disorders, and dysarthria; it also helps to resolve turbidity and improve secondary symptoms such as bowel and bladder dysfunction, sleep disorders, and mental disorders, promoting patient compliance, slowing and stabilizing disease progression, and improving patients' quality of life.

This invention discloses a traditional Chinese medicine composition for treating vascular cognitive impairment, its preparation method, and its application, belonging to the field of traditional Chinese medicine technology. It includes the following raw materials: stir-fried Atractylodes macrocephala, Fritillaria thunbergii, Ligusticum chuanxiong, Salvia miltiorrhiza, Curcuma longa, Acorus tatarinowii, Polygala tenuifolia, Cornus officinalis, Cistanche deserticola, Rehmannia glutinosa, Scrophularia ningpoensis, and borneol. Preparation method: First, the volatile oil is extracted by steam distillation and encapsulated with β-cyclodextrin; then, the lipid-soluble components in Salvia miltiorrhiza and Fritillaria thunbergii are extracted with ethanol; finally, the residue is combined with the remaining medicinal materials and decocted in water for extraction. Through the combination of Fritillaria thunbergii and borneol, the dual functions of "clearing inflammation + opening the blood-brain barrier" are achieved, increasing the brain concentration of lipid-soluble components such as tanshinone IIA. It significantly improves the learning and memory abilities of rats with vascular cognitive impairment, with efficacy superior to the Western medicine donepezil, and exhibits synergistic effects on multiple targets such as inhibiting NLRP3 inflammasomes and upregulating BDNF. This invention has a simple process, is suitable for industrial production, and has significant clinical application value.

The application discloses a natural medicine compound for treating Alzheimer's disease and application thereof, and the compound comprises the following components: 3-6 parts of Gastrodia elata, 3-6 parts of Polygala, 3-6 parts of Radix Notoginseng, 3-6 parts of Uncaria, 9-15 parts of Radix Rehmanniae Preparata, 9-15 parts of Radix Anemarrhenae, 6-10 parts of Fructus Schisandrae, 6-9 parts of Fried Semen Ziziphi Preparatum, 2-5 parts of Chuanxiong Rhizoma, 3-6 parts of Radix Paeoniae Alba, 9-15 parts of Radix et Rhizoma Bambusae, 1-5 parts of Carthamus, 6-10 parts of Atractylodes, 6-9 parts of Poria, 9-15 parts of Ophiophagus, 3-9 parts of Angelica, 9-15 parts of Radix et Rhizoma Ginseng, 2-5 parts of Salvia, and 2-5 parts of Radix Glycyrrhizae. The application further discloses a pharmacological action mechanism of the Tianqi granules for treating AD and application of the Tianqi granules in preventing and / or treating Alzheimer's disease. The application is a natural medicine, contains multiple active components, has scientific dosage, no side effect, and provides a new effective natural medicine compound for treating AD, and plays a significant role in benefiting a large number of patients and benefiting human health.

This invention discloses a herbal paste for improving cognitive function and its preparation method, prepared from the following raw materials in parts by weight: Kidney-tonifying and marrow-nourishing components: 10-50 parts Rehmannia glutinosa, 10-50 parts Dioscorea opposita, 10-30 parts Cornus officinalis, 20-50 parts Tortoise shell glue, 20-50 parts Deer antler glue, 20-50 parts Dendrobium nobile; Spleen-tonifying and qi-boosting components: 10-15 parts Poria cocos, 5-50 parts Panax ginseng, 10-20 parts Atractylodes lancea, 10-30 parts Atractylodes macrocephala, 3-10 parts Amomum villosum; Phlegm-resolving and orifice-opening components: 10 parts Pinellia ternata. -15 parts, Citrus aurantium 6-9 parts, Bambusa textilis 6-12 parts, Citrus reticulata 6-9 parts, Acorus tatarinowii 5-15 parts, Polygala tenuifolia 10-20 parts, Alpinia oxyphylla 10-20 parts; Through the TCM theory of multi-dimensional synergistic regulation of "tonifying the kidney and replenishing essence, strengthening the spleen and replenishing qi, resolving phlegm and opening the orifices, clearing heat and promoting blood circulation, and warming yang and promoting qi circulation", combined with the systematic optimization of preparation processes such as water extraction-alcohol extraction synergistic extraction, β-cyclodextrin inclusion and vacuum concentration, a paste formula is provided to improve cognitive function and related psychosomatic symptoms, and improve the compliance and bioavailability of the medicine.

This invention belongs to the technical field of traditional Chinese medicine preparation methods, specifically relating to a method for preparing a processed Polygala tenuifolia extract for treating uremia. The preparation method includes step 1: mixing cleaned Polygala tenuifolia slices with Evodia rutaecarpa juice, allowing the mixture to soak and absorb the juice completely, then stir-frying and drying to obtain processed Polygala tenuifolia prepared with Evodia rutaecarpa juice; step 2: soaking the above processed Polygala tenuifolia in pure water, decocting twice, combining the two filtrates, and concentrating the decoction to a concentration of 0.9429 g / ml to obtain the processed Polygala tenuifolia extract. This preparation method clarifies the processing technology of processed Polygala tenuifolia prepared with Evodia rutaecarpa juice and its efficacy in treating uremia, providing a foundation for new drug development. The processed Polygala tenuifolia extract obtained by this method has a good therapeutic effect on uremia.